Global Hip Replacement Market Report to 2028 – Featuring Zimmer Biomet, Stryker, Colfax and Microport Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Hip Replacement Market Report with Covid Impact – Global – 2022-2028 – MedCore” report has been added to ResearchAndMarkets.com’s offering. The total global hip replacement market is growing at a rate of 5.3%, which will take the 2021 market value of $8.7 billion up to $12.5 billion by 2028. Companies Mentioned Zimmer Biomet … [Read more…]

Biocom California Appoints Miguel Motta as Vice President of Strategic Operations and Head of its San Diego Office

SAN FRANCISCO & LOS ANGELES & SAN DIEGO–(BUSINESS WIRE)–Biocom California, the association representing the California life science industry, today announced the appointment of Miguel Motta as the organization’s vice president of strategic operations and head of its San Diego regional office. “Miguel’s strong history of leadership in life science companies will be important as we … [Read more…]

Tevogen Bio Appoints Acclaimed Oncologist and Immunotherapy Expert Neal Flomenberg, M.D. as Chief Scientific Officer and Global Head of R&D

Acclaimed oncologist and immunotherapy expert Neal Flomenberg, M.D. joins Tevogen Bio as Chief Scientific Officer (CSO) and Global Head of Research & Development Dr. Flomenberg most recently served as Professor and Chairman of the Department of Medical Oncology and Deputy Director of Sidney Kimmel Cancer Center of Thomas Jefferson University & Hospital, Philadelphia Dr. Flomenberg … [Read more…]

Mary Kay Inc. Partners With Dr. Jack Gilbert to Further Study Skin’s “Microbiome” and the Impact on the Aging Process

DALLAS–(BUSINESS WIRE)–Mary Kay Inc., one of the world’s leading skincare research companies, has announced a new partnership with Dr. Jack Gilbert, professor of pediatrics at the University of California San Diego School of Medicine and professor of microbial oceanography at UC San Diego Scripps Institution of Oceanography. Through the partnership, scientists at Mary Kay will … [Read more…]

Childhood Absence Epilepsy Treatment Market Report 2022-2027: High Prevalence of Epilepsy in Children and Rising Funding from Contract Research Organizations Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Childhood Absence Epilepsy Treatment Market Research Report by Drug (Lamotrigine, Phase 2 Drugs, and Valproate), Disease Type, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Childhood Absence Epilepsy Treatment Market size was estimated … [Read more…]

U.S. Acne Drugs Market to Reach $1.94 Billion by 2027 at a CAGR of 9.63% – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Acne Drugs Market Research Report by Acne Type (Comedonal, Cystic, and Inflammatory), Drug Class, Drug Type, Route of Administration, State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The United States Acne Drugs Market size was estimated at USD 1,119.50 million in 2021, … [Read more…]

Monoclonal Antibodies for Oncology Global Market Report 2022: Featuring Key Players GlaxoSmithKline, AstraZeneca, Merck & Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Monoclonal Antibodies for Oncology: Global Markets” report has been added to ResearchAndMarkets.com’s offering. The current report provides detailed exposure of global monoclonal antibodies for the oncology market. This report highlights the current and future market potential of monoclonal antibodies for oncology treatment and includes a detailed analysis of the market’s drivers, challenges, and … [Read more…]

Latest Prescription Drug Price Negotiation Draft Takes Two Steps Back for Seniors

WASHINGTON–(BUSINESS WIRE)–#FacesofAcceleratedApproval–The Partnership to Fight Chronic Disease (PFCD) released the following statement today regarding the Prescription Drug Pricing Reform proposal aiming to lower drug prices through government negotiation under Medicare: “More than half of U.S. adults are living with at least one chronic condition and four in ten adults live with two or more. For … [Read more…]

Burke Neurological Institute Receives a $45 Million NIH Grant to Study a Vitamin B1 Precursor for Treatment of Alzheimer’s Disease in Multi-center Clinical Trial

WHITE PLAINS, N.Y.–(BUSINESS WIRE)–The Burke Neurological Institute (BNI) has received a five year award expected to total $45 million from the National Institutes of Health (NIH) to launch a large-scale, multi-center clinical trial to evaluate benfotiamine, a synthetic precursor of thiamine (vitamin B1), as a potentially effective therapy for mild Alzheimer’s disease (AD) or mild … [Read more…]

Hims & Hers Health, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 8, 2022

SAN FRANCISCO–(BUSINESS WIRE)–Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, will release its second quarter 2022 financial results on Monday, August 8, 2022 at 4:15 p.m. E.T., with a conference call to follow at 5:00 p.m. E.T. Conference … [Read more…]